Reference number : 172-2021-2022-Q3-980818, amendment number : , agreement type : C, recipient legal name : Rakovina Therapeutics Inc., recipient country : CA, recipient province : BC, recipient city : Vancouver|Vancouver, recipient postal code : V6B 0A5, program name english : Industrial Research Assistance Program – Contributions to Firms, program name french : Programme d’aide à la recherche industrielle – Contributions aux entreprises, program purpose english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, program purpose french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, agreement title english : Lead optimization  of anti-cancer agents, agreement title french : Optimiser des agents anticancéreux, agreement number : 980818, agreement value : 56803.0, agreement start date : 2021-10-11, agreement end date : 2022-03-15, description english : Lead optimization of a novel class of small molecule anti-cancer agents through evaluation of their pharmacokinetic profiles and ability to penetrate the blood brain barrier., description french : Optimiser une nouvelle classe de petites molécules anticancéreuses en évaluant leur profil pharmacocinétique et leur capacité à pénétrer la barrière hémato-encéphalique., expected results english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, expected results french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, additional information english : nan, additional information french : nan, owner organization : nrc-cnrc, owner organization title : National Research Council Canada | Conseil national de recherches Canada